Have you seen gene editing and sequencing stocks recently? Source: Connect world / Shutterstock.com Illumina (NASDAQ:ILMN) is up 20% over the past three months. Beam Therapeutics (NASDAQ:BEAM) is up 45%. Editas Medicine (NASDAQ:EDIT) is up 90%. Intellia Therapeutics (NASDAQ:NTLA) is up 150%. Folks, the Genomic Revolution is here. And while everyone can see those big
0 Comments
A leader in the online sports gambling industry, DraftKings (NASDAQ:DKNG) is expanding its presence across the States and is expected to benefit from the upcoming football season. The company is making well-timed moves to build new offerings and achieve growth. It has successfully partnered with some of the top sports companies to offer a unique experience
0 Comments
Since before Robinhood (NASDAQ:HOOD) stock went public a month ago, the phrase “Robinhood stock” has been part of the vocabulary. Source: dennizn / Shutterstock.com These are stocks beloved of small investors, who often trade on Robinhood’s app and exchange views on Reddit’s r/Wallstreetbets. But after looking at its June quarter earnings report and what has
0 Comments
U.S. equity markets rebounded this week with the Nasdaq and S&P 500 leading the gains as investors focused on more strong earnings reports and hopes that corporate profits will continue to expand in the third and fourth quarters. Those profits will be challenged by uncertainty around the delta variant and the impact it could have
0 Comments
Novavax (NASDAQ:NVAX) stock could trade in the $100 billion market capitalization range like BioNTech (NASDAQ:BNTX) or Moderna (NASDAQ:MRNA). Except, unlike those companies, Novavax has not yet delivered. Source: Ascannio/Shutterstock.com It might be among the most-watched firms that did not yet bring a Covid-19 vaccine to market. Chances are low that it will slump like Altimmune
0 Comments
These ETFs can be used for short-term trading or hedging. ProShares Short S&P500: https://www.zacks.com/funds/etf/SH/profile?cid=CS-YOUTUBE-FT-VID SPDR S&P 500 ETF: https://www.zacks.com/funds/etf/SPY/profile?cid=CS-YOUTUBE-FT-VID ProShares UltraShort S&P500: https://www.zacks.com/funds/etf/SDS/profile?cid=CS-YOUTUBE-FT-VID ProShares UltraPro Short S&P500: https://www.zacks.com/funds/etf/SPXU/profile?cid=CS-YOUTUBE-FT-VID Direxion Daily S&P 500 Bear 1X Shares: https://www.zacks.com/funds/etf/SPDN/profile?cid=CS-YOUTUBE-FT-VID Direxion Daily S&P 500 Bear 3X Shares: https://www.zacks.com/funds/etf/SPXS/profile?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow us on Twitter: https://twitter.com/ZacksResearch Like
0 Comments
After Digital Turbine (NASDAQ:APPS) posted its fiscal first-quarter results, investors appeared to be disappointed by its earnings. APPS stock fell after the earnings report, despite providing good fiscal Q2 guidance. Indeed, the mobile advertising platform firm has multiple catalysts ahead that will sustain the company’s growth. Source: Apple.com The Street is shortsighted as usual and
0 Comments